Boris Peaker Analyst PerformanceManaging Director at JonesTradingBoris Peaker is a stock analyst at JonesTrading in the medical sector, covering 25 publicly traded companies. Over the past year, Boris Peaker has issued 4 stock ratings, including strong buy, buy, and hold recommendations. While full access to Boris Peaker's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Boris Peaker's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings104 Last 11 YearsBuy Recommendations76.92% 80 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution104RatingsDistribution of strong buy, buy, hold, and sell ratings by Boris Peaker.RatingPercentageCount Strong Buy1.0%1 ratings Buy76.0%79 ratings Hold23.1%24 ratings Sell0.0%0 ratingsOut of 104 total stock ratings issued by Boris Peaker at JonesTrading, the majority (76.0%) have been Buy recommendations, followed by 23.1% Hold and 1.0% Strong Buy.Best & Worst CallsBest Call0000.0%GLYCMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CLDXJun 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.0% of companies on NASDAQ24 companiesNYSE4.0% of companies on NYSE1 companyBoris Peaker, an analyst at JonesTrading, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies100.0%Boris Peaker of JonesTrading specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE12 companies48.0%MED - DRUGS5 companies20.0%PHARMACEUTICAL PREPARATIONS4 companies16.0%BIOTECHNOLOGY2 companies8.0%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company4.0%MED PRODUCTS1 company4.0% Boris Peaker's Ratings History at JonesTrading Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRLAYRelay Therapeutics5/19/2026Upgrade$13.02Strong-Buy$0.0000.00% ROIANLAdlai Nortye5/14/2026Initiated Coverage$13.86$22.00Buy$0.0000.00% ROIJANXJanux Therapeutics4/28/2026Lower Price Target$14.37$28.00Buy$0.0000.00% ROIRLAYRelay Therapeutics4/14/2026Initiated Coverage$15.26$18.00Hold$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupStifel NicolausKeyCorpBerenberg BankItau BBA SecuritiesWells Fargo & CompanyBMO Capital MarketsScotiabank Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
